Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

BACKGROUND: Median survival of non-small cell lung cancer (NSCLC) patients with brain metastases is poor. We examined concurrent erlotinib and whole brain radiotherapy (WBRT) followed by maintenance erlotinib in patients with untreated brain metastases, given the potential radiosensitizing propertie...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lee, Siow Ming, Lewanski, Conrad R., Counsell, Nicholas, Ottensmeier, Christian, Bates, Andrew, Patel, Nirali, Wadsworth, Christina, Ngai, Yenting, Hackshaw, Allan, Faivre-Finn, Corinne
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112798/
https://ncbi.nlm.nih.gov/pubmed/25031274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju151
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller